New Foundayo Data Push Back on the Liver Safety Narrative
For much of Foundayo’s development, one of the biggest questions around the drug was whether the liver would become a problem.
On The Pen | GLP-1 & Obesity Medicine News
On The Pen Patient Tool
Find My Trial
Find obesity and metabolic clinical trials that may be relevant to you, then connect directly with the study team when contact information is available.
Find My Trial1,795 recruiting studies tracked across 392 treatments — sourced from ClinicalTrials.gov.
Top Stories
The most-read On The Pen stories, ranked by reader engagement.
Novo Nordisk Just Changed the Childhood Obesity Conversation
New data helps to bolster the case for early pharmacologic obesity interventions.
Latest News
The Weekly Dose
On The Pen's flagship podcast — obesity medicine, unfiltered.
Recent Livestreams
Obesity.News
Stay ahead of obesity medicine.
Breaking GLP-1 news, drug development, access updates, and patient-centered analysis, all in one place.
- Breaking obesity medicine and GLP-1 news
- The latest from The Weekly Dose podcast
- Live talk show every Monday, Wednesday, and Friday at 11 AM CT
- Deeper reporting and analysis for paid subscribers
Empowering you to have better conversations with your doctor.
On The Pen covers obesity medicine from the patient's side of the exam table — GLP-1s, access, and the science, reported plainly.
Sponsors & Partners